July 2026
Added to Dediabetes Jul 12, 2026RCTs
This study examined the implementation of a mobile health (mHealth) intervention aimed at increasing nonexercise physical activity in patients with Type 2 Diabetes, with unclear effectiveness.
Interventions
mHealth intervention with personal feedback
Outcomes
Acceptability of mHealth interventionFidelity of mHealth interventionPerceived behavior change needs
Added to Dediabetes Jul 12, 2026RCTs
This study explored engagement patterns in a mobile health intervention for women at risk of gestational diabetes, revealing varied engagement clusters.
Interventions
Mobile app for diabetes self-management
Outcomes
Patient engagement
Added to Dediabetes Jul 12, 2026RCTs
The study evaluated semaglutide, a glucagon-like peptide-1 receptor agonist, for managing high cardiovascular risk and found significant reductions in major renal events and cardiovascular risks.
Outcomes
All-cause mortalityAnnual rate of change in eGFRCardiovascular events+2 more
Added to Dediabetes Jul 12, 2026RCTs
A values-guided self-management intervention showed potential to improve glucose control in emerging adults with type 1 diabetes.
Outcomes
Diabetes-specific acceptanceInterstitial glucose level measured in mg/dLProgress towards valued living+2 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the accuracy and feasibility of real-time continuous glucose monitoring (CGM) in early postoperative intensive care after liver transplantation.
Interventions
Continuous glucose monitoring
Outcomes
DTS Error Grid Zone AMean Absolute Relative Difference (MARD)Sensor Accuracy Over Time
Added to Dediabetes Jul 12, 2026RCTs
This study investigated the effects of dapagliflozin on cardiovascular outcomes in diabetic patients, revealing significant changes in plasma IL-1B and ketones.
Interventions
Dapagliflozin
Outcomes
Extracellular volumeGlobal myocardial strainInterleukin-6 (IL-6)+6 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the effectiveness of eldecalcitol in preventing type 2 diabetes in adults with impaired glucose tolerance. It found no significant difference in diabetes incidence between eldecalcitol and placebo groups.
Interventions
Eldecalcitol
Outcomes
Bone mineral density (BMD)Regression to normoglycaemiaSerum osteocalcin+1 more
Added to Dediabetes Jul 12, 2026RCTs
This study compared Family-DSMES and Standard-DSMES in participants with diabetes, finding significant improvements in diabetes-related family involvement with Family-DSMES.
Outcomes
HbA1cImprovement in diabetes-related helpful family involvement
Added to Dediabetes Jul 12, 2026RCTs
This study analyzed the relationship between insulin-like growth factor-1 (IGF-1) levels and cardiovascular outcomes in hyperglycemic acute coronary syndrome patients, finding no independent association with major adverse cardiovascular events.
Interventions
Intensive glycemic control
Outcomes
Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)Post-ACS myocardial infarct size and left ventricular functionType 2 diabetes incidence
Added to Dediabetes Jul 12, 2026RCTs
The ASCEND-Eye study assessed the effects of aspirin and omega-3 fatty acids on diabetic eye screening data, finding significant reductions in blood lactate and growth differentiation factor 15.
Interventions
AspirinOmega-3 Fatty Acid Supplementation
Outcomes
Blood lactate concentrationGrowth differentiation factor 15Hypoglycemia symptom recognition ability+2 more